SCHEMBL2584142

SCHEMBL2584142

CCCC(=O)N1CCC2(CC1)CC(C(=O)Nc1ccccc1)=NO2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.49
USP2 O75604 1/20 0.49
POLB P06746 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
LMNA P02545 1/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
GPR119 Q8TDV5 3/20 0.42
NAMPT P43490 2/20 0.41
CYP2C19 P33261 4/20 0.40
CYP2C9 P11712 2/20 0.40
CYP3A4 P08684 1/20 0.40
RECQL P46063 1/20 0.40
GAA P10253 1/20 0.40
OPRM1 P35372 1/20 0.40
OPRL1 P41146 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
JAK2 O60674 1/20 0.40
JAK1 P23458 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6409773 0.82 MAPT (0.42) MAPTUSP2POLBSMN1; SMN2LMNA
SCHEMBL2400832 0.81 GPR119 (0.37) MAPTUSP2POLBGPR119NAMPT
SCHEMBL2401980 0.78 TSHR (0.46) MAPTUSP2POLBMAPK1HTT
SCHEMBL2399685 0.76 SMN1; SMN2 (0.43) SMN1; SMN2HTTGPR119GAAJAK2
SCHEMBL2401291 0.74 L3MBTL1 (0.47) MAPTPOLBLMNAGPR119MEN1
SCHEMBL2402983 0.73 L3MBTL1 (0.46) POLBSMN1; SMN2LMNAMAPK1HTT
SCHEMBL2400307 0.72 CYP2D6 (0.44) MAPTMAPK1CYP2C19GAACYP1A2
SCHEMBL2402651 0.71 HPGD (0.43) MAPTUSP2SMN1; SMN2LMNAHTT
SCHEMBL2399298 0.71 RAB9A (0.56) MAPTUSP2POLBSMN1; SMN2MAPK1
SCHEMBL2404697 0.71 GNAI3 (0.39) GPR119CYP2C19CYP3A4RECQLMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8048890-B2 Analgesics; neuropathic pain; headaches; muscle relaxants; incontence; tinnitus; diarrhea; antiarrhythmia agents; antiischemic agents; antiinflammatory agents; antiulcer agents; antidepressants; antiepileptic agents GRUENENTHAL GMBH (DE) 2011-11-01 US claimed
EP-1401841-B1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN GRUENENTHAL GMBH (DE) 2005-08-24 EP claimed